Generic Medicine: A Comprehensive Analysis

Why in news?

India's Generic Drug Reputation at Risk Amid Controversies Over Contaminated Medicines, Regulatory Loopholes, and Global Health Safety Concerns.

Introduction to Generic Medicine

• Definition: Generic medicine is a pharmaceutical drug that contains the same active ingredients, dosage form, strength, and administration route as a branded drug but is sold under its chemical name rather than a brand name.
• Purpose: It offers a cost-effective alternative to branded medications while ensuring similar efficacy and safety.
• Global Recognition: Organizations like the World Health Organization (WHO), U.S. FDA, and European Medicines Agency (EMA) regulate and approve generic medicines.

Production of Generic Medicines

a) Manufacturing Process

• Patent Expiry: Generic medicines can be produced once the patent of a branded drug expires (usually after 20 years).
• Approval Process: Generic drugs undergo regulatory approval to ensure they match the original drug in:
  • Active pharmaceutical ingredient (API)
  • Dosage form and strength
  • Bioavailability and pharmacokinetics
• Manufacturing Standards: Generic drugs are produced under Good Manufacturing Practices (GMP) to ensure quality and safety.
• Testing & Approval:
  • Bioequivalence testing ensures that the generic drug performs the same as the branded one.
  • Clinical trials may be required in certain cases.
• Distribution & Pricing: After approval, they are sold at a lower price due to lesser research and marketing costs.

Legal and Regulatory Status

a) Approval Process Across Countries

• United States: Approved by the Food and Drug Administration (FDA) under the Abbreviated New Drug Application (ANDA).
• India: Regulated by the Central Drugs Standard Control Organization (CDSCO) and produced under the Drugs and Cosmetics Act, 1940.
• European Union: Approved by the European Medicines Agency (EMA) under a bioequivalence framework.

b) Patent Laws and Generic Drug Market

• Patent Expiry Rule: Once the patent protection expires, pharmaceutical companies can produce generic versions.
• Compulsory Licensing: Governments can issue compulsory licenses in cases of emergencies, allowing generic drug production before patent expiry.
• TRIPS Agreement: Trade-Related Aspects of Intellectual Property Rights (TRIPS) governs international patent laws, influencing the availability of generics.

Effects on Public and Healthcare System

a) Benefits to Public Health

• Affordable Healthcare: Generic medicines are 70-90% cheaper than branded drugs, making them accessible to a larger population.
• Wider Availability: Helps in treating chronic diseases like diabetes, hypertension, and tuberculosis at lower costs.
• Encourages Competition: The availability of generics promotes a competitive market, leading to overall price reductions.
• Reduces Healthcare Costs: Governments and insurance companies save billions by including generics in public healthcare programs.

b) Challenges in Public Acceptance

• Perceived Inferiority: Many patients and doctors believe branded drugs are superior, despite scientific evidence proving equivalence.
• Lack of Awareness: Limited knowledge about generic medicines reduces their acceptance in many regions.
• Prescription Barriers: Some doctors prefer prescribing branded drugs due to ties with pharmaceutical companies.

Advantages of Generic Medicines

• Cost-Effective Alternative: Generic medicines provide high-quality treatment at a fraction of the cost of branded drugs.
• Increases Healthcare Access: Affordable drugs allow low-income populations to receive essential medications.
• Regulatory Standards Ensure Safety: Strict bioequivalence testing ensures that generics function the same as original drugs.
• Faster Market Availability: No need for extensive clinical trials, making them available sooner than new drugs.
• Boosts Pharmaceutical Industry Growth: Generic drug production helps small and mid-sized pharmaceutical companies thrive.
• Enhances Competition in the Market: Prevents monopolies by big pharma companies, reducing drug prices.
• Sustainable Healthcare System: Governments can divert healthcare budgets to other critical areas like disease prevention.

Limitations of Generic Medicines

• Variability in Inactive Ingredients: Generic drugs may contain different excipients, which can affect drug absorption in sensitive individuals.
• Delayed Market Entry Due to Legal Battles: Patent litigations and evergreening tactics by big pharma delay generic drug approvals.
• Availability Issues: Some generics are not widely available, especially in rural areas.
• Doctor and Patient Skepticism: Some healthcare professionals doubt the effectiveness of generics, leading to lower prescription rates.
• Brand Influence on Prescription Trends: Pharmaceutical companies influence doctors to prescribe their branded medicines through aggressive marketing.
• Quality Variations in Unregulated Markets: Some regions have poor regulatory oversight, leading to low-quality generic drugs entering the market.

The Way Forward: Promoting Generic Medicine Usage

a) Policy Interventions

• Stronger Government Regulations:
  • Governments should mandate bioequivalence testing for all generics.
  • Strict action against substandard generics should be enforced.
• Compulsory Prescription of Generics:
  • Policies should encourage doctors to prescribe generics by default.
  • Pharmacists should be allowed to substitute generics for brand-name drugs unless medically necessary.
• Price Control Mechanisms:
  • Governments should regulate maximum retail prices (MRP) of generic medicines.
  • Preventing price manipulation by pharma companies ensures affordability.

b) Increasing Public Awareness

• Awareness Campaigns:
  • Government and NGOs should promote educational initiatives on generic medicines.
  • Social media, TV ads, and community programs can change public perception.
• Medical Community Engagement:
  • Conducting training programs for doctors and pharmacists to instill confidence in generic medicine efficacy.
  • Reducing influence of pharma companies on prescription trends.

c) Strengthening the Supply Chain

• Improving Availability in Rural Areas:
  • Establishing generic drug stores in remote locations.
  • Jan Aushadhi Kendras in India provide affordable generic medicines.
• Encouraging Local Production:
  • Promoting domestic pharmaceutical companies to reduce reliance on imports.
  • Government incentives for generic drug manufacturers.

Conclusion

• Generic medicines play a vital role in global healthcare, offering an affordable and effective alternative to branded drugs. Despite challenges such as public skepticism, patent barriers, and marketing dominance by big pharma, governments and healthcare agencies can boost generic medicine adoption through policy reforms, awareness programs, and stronger regulations. Strengthening the supply chain and market accessibility will further ensure universal healthcare access, making quality medications affordable for all.
• By embracing generic medicines, nations can move towards a sustainable, cost-effective, and equitable healthcare system, benefiting millions worldwide.